Changes to EU guidelines on device clinical investigation on the agenda
This article was originally published in Clinica
Changes to two important EU medical device guidelines – on competent authority assessment of a medical device clinical investigation, and on reporting serious adverse events associated with devices during a clinical investigation – will be presented before the European Commission's Medical Devices Experts Group on 28 May for approval.
You may also be interested in...
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.